- Home
- ZNTL vs CBFV Comparison
ZNTL vs CBFV Comparison
Compare ZNTL & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- CBFV
- Stock Information
- Founded
- ZNTL 2014
- CBFV 1901
- Country
- ZNTL United States
- CBFV United States
- Employees
- ZNTL N/A
- CBFV N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- CBFV Major Banks
- Sector
- ZNTL Health Care
- CBFV Finance
- Exchange
- ZNTL Nasdaq
- CBFV Nasdaq
- Market Cap
- ZNTL 137.9M
- CBFV 148.0M
- IPO Year
- ZNTL 2020
- CBFV N/A
- Fundamental
- Price
- ZNTL $1.29
- CBFV $28.63
- Analyst Decision
- ZNTL Buy
- CBFV Hold
- Analyst Count
- ZNTL 8
- CBFV 2
- Target Price
- ZNTL $8.53
- CBFV $26.00
- AVG Volume (30 Days)
- ZNTL 927.8K
- CBFV 12.9K
- Earning Date
- ZNTL 05-06-2025
- CBFV 04-29-2025
- Dividend Yield
- ZNTL N/A
- CBFV 3.49%
- EPS Growth
- ZNTL N/A
- CBFV N/A
- EPS
- ZNTL N/A
- CBFV 2.38
- Revenue
- ZNTL $67,425,000.00
- CBFV $50,028,000.00
- Revenue This Year
- ZNTL N/A
- CBFV $8.55
- Revenue Next Year
- ZNTL N/A
- CBFV $9.01
- P/E Ratio
- ZNTL N/A
- CBFV $12.03
- Revenue Growth
- ZNTL N/A
- CBFV N/A
- 52 Week Low
- ZNTL $1.01
- CBFV $20.75
- 52 Week High
- ZNTL $13.46
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.50
- CBFV 56.40
- Support Level
- ZNTL $1.01
- CBFV $26.04
- Resistance Level
- ZNTL $1.32
- CBFV $28.64
- Average True Range (ATR)
- ZNTL 0.14
- CBFV 0.77
- MACD
- ZNTL 0.02
- CBFV 0.13
- Stochastic Oscillator
- ZNTL 37.33
- CBFV 93.24
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.